Generate a tailored SOP for Dr. Andrew Aronsohn. Improve your application with a focused, well-structured draft.
Andrew Aronsohn, MD, is an Associate Professor in the Department of Medicine at the University of Chicago. He specializes in the diagnosis and treatment of liver disease, particularly focusing on hepatitis C, liver cancer, and liver diseases. Dr. Aronsohn is also engaged in medical management of liver transplantation. He is a faculty member at the MacLean Center for Clinical Medical Ethics and directs the hepatitis curriculum for ECHO Chicago, which aims to educate and empower primary care providers to manage hepatitis C in local settings. His research interests include the ethical implications of hepatitis C therapy and the fair distribution of resources and linkage to care. He has contributed to significant research published in prestigious journals covering topics such as fecal metabolite profiling, stigma in hepatitis C virus care, and multilevel interventions for vulnerable populations. Dr. Aronsohn actively participates in committees related to the elimination of hepatitis B and C, reflecting his commitment to advancing liver disease treatment and ethics.
Department of Philosophy